Literature DB >> 31680721

Ablation plus Transarterial Embolic Therapy for Hepatocellular Carcinoma Larger than 3 cm: Science, Evidence, and Future Directions.

Andrew R Lewis1, Carlos A Padula1, J Mark McKinney1, Beau B Toskich1.   

Abstract

Thermal ablation is widely regarded as definitive therapy for early-stage hepatocellular carcinoma, but its efficacy decreases in tumors greater than 3 cm. Extensive clinical studies have supported improved outcomes provided through combining transarterial embolic therapy with ablation in the treatment of larger tumors. This article will provide a survey of the science and data for combination therapy in both thermal and nonthermal ablation modalities, as well as describe emerging applications. © Thieme Medical Publishers.

Entities:  

Keywords:  ablation; combination therapy; cryoablation; embolization; hepatocellular carcinoma; microwave ablation; radiofrequency ablation; thermal ablation; transarterial chemoembolization; transarterial embolization

Year:  2019        PMID： 31680721      PMCID： PMC6823040          DOI： 10.1055/s-0039-1697641

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  71 in total

Review 1.  Thermal ablation and immunomodulation: From preclinical experiments to clinical trials.

Authors:  H Takaki; F Cornelis; Y Kako; K Kobayashi; N Kamikonya; K Yamakado
Journal:  Diagn Interv Imaging       Date:  2017-06-01       Impact factor: 4.026

Review 2.  Minimally invasive therapies for hepatic malignancy.

Authors:  Lawrence M Knab; Riad Salem; David M Mahvi
Journal:  Curr Probl Surg       Date:  2013-04       Impact factor: 1.909

3.  Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study.

Authors:  Siddharth A Padia; Guy E Johnson; Kathryn J Horton; Christopher R Ingraham; Matthew J Kogut; Sharon Kwan; Sandeep Vaidya; Wayne L Monsky; James O Park; Renuka Bhattacharya; Daniel S Hippe; William P Harris
Journal:  J Vasc Interv Radiol       Date:  2017-03-30       Impact factor: 3.464

4.  Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Yang Fu; Xu Zhao; Qiang Yun; Xueming Zhu; Yong Zhu; Quanwang Li; Kaiwen Hu; Jinwan Wang; Zhanbing Qiao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

6.  Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.

Authors:  Francesco Saverio Ferrari; Andrea Stella; Daniela Gambacorta; Fabrizio Magnolfi; Federica Fantozzi; Paolo Pasquinucci; Letizia Civeli; Massimo Pieraccini
Journal:  Radiol Med       Date:  2004-10       Impact factor: 3.469

7.  Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis.

Authors:  Claudio Maurizio Pacella; Giancarlo Bizzarri; Giampiero Francica; Antonio Bianchini; Stefano De Nuntis; Sara Pacella; Anna Crescenzi; Silvia Taccogna; Giuseppe Forlini; Zaccaria Rossi; John Osborn; Roberto Stasi
Journal:  J Vasc Interv Radiol       Date:  2005-11       Impact factor: 3.464

8.  Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection.

Authors:  K Tanaka; H Okazaki; S Nakamura; O Endo; S Inoue; Y Takamura; M Sugiyama; Y Ohaki
Journal:  Radiology       Date:  1991-06       Impact factor: 11.105

9.  Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.

Authors:  Karen T Brown; Richard K Do; Mithat Gonen; Anne M Covey; George I Getrajdman; Constantinos T Sofocleous; William R Jarnagin; Michael I D'Angelica; Peter J Allen; Joseph P Erinjeri; Lynn A Brody; Gerald P O'Neill; Kristian N Johnson; Alessandra R Garcia; Christopher Beattie; Binsheng Zhao; Stephen B Solomon; Lawrence H Schwartz; Ronald DeMatteo; Ghassan K Abou-Alfa
Journal:  J Clin Oncol       Date:  2016-02-01       Impact factor: 44.544

10.  Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Authors:  Shuichiro Shiina; Ryosuke Tateishi; Toru Arano; Koji Uchino; Kenichiro Enooku; Hayato Nakagawa; Yoshinari Asaoka; Takahisa Sato; Ryota Masuzaki; Yuji Kondo; Tadashi Goto; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike
Journal:  Am J Gastroenterol       Date:  2011-12-13       Impact factor: 10.864
View more
  2 in total

Review 1.  Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?

Authors:  Zeno Sparchez; Pompilia Radu; Adrian Bartos; Iuliana Nenu; Rares Craciun; Tudor Mocan; Adelina Horhat; Mihaela Spârchez; Jean-François Dufour
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

2.  Image-Guided Peri-Tumoral Radiofrequency Hyperthermia-Enhanced Direct Chemo-Destruction of Hepatic Tumor Margins.

Authors:  Minjiang Chen; Feng Zhang; Jingjing Song; Qiaoyou Weng; Peicheng Li; Qiang Li; Kun Qian; Hongxiu Ji; Sean Pietrini; Jiansong Ji; Xiaoming Yang
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.